New Poisoning Research Highlights ED Guidelines, Methanol Mortality Markers, Paraquat Risk Signs, and AI Safety in Toxicology

New human research is pointing to faster and more structured ways to assess poisoning patients in emergency care, from unknown exposures to methanol outbreaks and rare industrial poisonings.

The latest PubMed update does not reveal a single new universal antidote. Instead, it shows a practical shift in toxicology: clinicians are being given better tools to decide who is at risk, who needs intensive care, and when early treatment should be escalated.

The strongest papers focus on suspected but unidentified poisoning, methanol poisoning, paraquat poisoning, organotin poisoning, artificial intelligence in clinical documentation, and poisoning in older adults [1–6].

Together, they suggest that poisoning care is becoming more protocol-driven, more data-informed and more cautious about patients who may look stable at first. This broader shift toward mechanism-based toxicology is also discussed in How Mechanistic Medical Toxicology Is Shaping Next-Generation Patient Care.

New guidance for unidentified poisoning in the emergency department

One of the most directly useful updates is a joint best practice guideline from the Royal College of Emergency Medicine and the National Poisons Information Service [1].

The guideline addresses one of the hardest situations in toxicology: a patient appears poisoned, but the substance is not yet known. It recommends a general clinical approach based on early stabilisation, toxidrome recognition, toxicokinetics, and repeated assessment rather than waiting for a confirmed toxin name [1].

This matters because the first emergency decision is often not “what exactly was taken?” but “is this patient deteriorating, and what needs to happen now?”

The guidance does not replace poison-specific advice or specialist toxicology resources. But it gives emergency teams a clearer framework for initial assessment, observation, investigation and escalation when the exposure is uncertain [1]. This is closely aligned with The Role of Poison Center Calls: Managing Poisoning Cases from Emergency Calls to Critical Decisions, which explains why early expert toxicology input can change emergency decision-making.

For clinicians, the message is simple: unknown poisoning should be managed actively, not passively. Airway, breathing, circulation, mental status, vital signs, glucose, acid-base status, ECG findings and likely toxidromes remain central to early decision-making [1].

Methanol outbreak data sharpen mortality prediction

A study from Istanbul examined patients treated during a methanol poisoning outbreak and found that arterial pH was the strongest predictor of in-hospital death.

The study included 55 adult patients. Mortality was high, with 25 deaths reported. Non-survivors had lower arterial pH, lower bicarbonate, worse base excess, higher lactate and higher anion gap than survivors [2].

The authors found that arterial pH had excellent prognostic performance. When arterial blood gas testing was not available, lactate and Glasgow Coma Scale score still offered useful warning signs.

This is clinically important because methanol poisoning can progress quickly to visual injury, severe acidosis, organ failure and death. Early recognition of high-risk patients can support faster decisions about antidotal therapy, haemodialysis and intensive care admission [2].

The study does not replace established methanol treatment protocols. But it strengthens the case for using early acid-base markers as urgent triage tools during outbreak settings [2]. For a related toxic alcohol emergency involving a different compound, What Happens If You Drink Antifreeze: Critical Symptoms You Can't Ignore provides useful clinical context on rapid recognition and treatment escalation.

Paraquat poisoning emerges as a growing toxicological crisis

A multicentre study from Bangladesh described paraquat poisoning as an emerging toxicological and public-health problem [3].

The study collected data across 10 tertiary hospitals. Reported cases rose sharply, from a single case in 2013 to 493 cases across the study sites in 2024 [3].

Among patients with available clinical data, common clinical features included acute kidney injury, vomiting and abdominal pain. The case fatality rate was high. Markers of poor prognosis included large ingestion, fever, “paraquat tongue,” acute kidney failure and low Glasgow Coma Scale score [3].

This matters because paraquat poisoning has limited treatment options and can be rapidly fatal. Early identification of poor prognostic signs may help clinicians prioritise transfer, intensive monitoring, supportive care and public-health reporting [3].

The authors also argued that banning agricultural paraquat use and replacing it with less toxic substitutes is urgently needed to reduce deaths and morbidity.

For emergency teams, the bedside message is that paraquat exposure should trigger early risk assessment. For public-health teams, the larger message is that regulatory action may be more effective than relying on hospital treatment after ingestion. This prevention message connects directly with Herbicides: Why the Name on the Bottle Is Not Enough, which explains why product identity and formulation details matter in herbicide-related poisoning.

Rare organotin poisoning report supports combined treatment approach

A small Chinese case series described four patients with acute organotin poisoning treated with haemoperfusion, continuous veno-venous haemodiafiltration and sodium dimercaptopropanesulfonate [4].

All four patients had high serum and urinary tin levels, hypokalaemia, neurological symptoms and metabolic disturbance before treatment. After combined therapy, serum and urinary tin levels fell, potassium normalised, and neurological symptoms improved or resolved [4].

All four patients recovered and were discharged.

Because this was a small retrospective case series, it should not be treated as definitive proof. But it is still clinically relevant because acute organotin poisoning is rare and potentially severe, and treatment evidence is limited.

The report suggests that combined blood purification with chelation and supportive care may be useful in selected severe cases, especially when neurological symptoms, metabolic acidosis and electrolyte abnormalities are present [4]. For broader background on metal-related toxicity and treatment concepts, see Understanding How Toxic Metals Impact Your Health.

AI may help poisoning documentation, but physician review remains essential

Another study examined whether large language models could generate initial senior physician ward round records for patients with acute poisoning.

Researchers compared DeepSeek, ChatGPT and human physician records in 256 acute poisoning cases. The AI systems performed well in several scoring categories, and DeepSeek scored highly for differential diagnosis and prognosis assessment.

But the most important safety point was cautionary: high-harm records were more frequent in the AI-generated groups than in the physician group [5].

That means AI may help with documentation, synthesis and structured thinking, but it should not replace clinical judgement. In acute poisoning, omissions or fabricated details can affect treatment direction, monitoring and prognosis assessment.

For now, the safest interpretation is that AI may become a useful assistant in toxicology documentation only when every output is reviewed by a qualified clinician before it enters the medical record [5]. This same documentation challenge is explored in AI for Poison Control: Toxicology Documentation & Speech-to-Text Tools.

Older poisoning patients need closer monitoring

A large Australian toxicology-service study found that poisoning in older adults is increasing and remains more severe than in younger adults [6].

The study compared 1,532 poisoning admissions in patients aged 65 years or older with 24,912 admissions in adults aged 19 to 64 [6].

Older patients had longer hospital stays, more intensive care admissions and higher mortality. They also had more cardiac complications, hypotension and acute kidney injury.

Severity increased with age, particularly among patients aged 85 years and older.

The results suggest that older poisoning patients should be treated as a higher-risk group, even when the initial exposure appears familiar. Cardiac medications, comorbidities, reduced physiological reserve and renal vulnerability can all alter the course of poisoning.

For emergency departments, this supports a lower threshold for ECG monitoring, renal function assessment, medication review and extended observation in older patients [6].

What this means for poisoning care

The clearest message from these studies is that poisoning care is moving earlier in the timeline.

Clinicians are being asked to identify risk before deterioration becomes obvious, to use structured frameworks when the toxin is unknown, and to recognise high-risk groups such as methanol outbreak patients, paraquat-exposed patients and older adults [1–3,6].

There is no single new treatment that applies to every poisoning patient. But the direction is consistent:

early toxidrome-based assessment [1];

stronger use of pH, lactate, GCS, kidney injury and ECG findings [2,3,6];

faster escalation for methanol and paraquat poisoning [2,3];

careful use of blood purification and chelation in selected rare poisonings [4];

mandatory physician oversight of AI-assisted documentation [5];

closer monitoring of older patients [6].

Most of the evidence still requires cautious interpretation. Several studies are retrospective, and some involve small numbers of patients. But the overall trend is important: toxicology is becoming more structured, more predictive and more focused on early decisions.

For patients and families, the practical advice has not changed. Suspected poisoning should be treated as urgent. Bring the product, container, label, medication list or exposure details when safe to do so. Early contact with poison centres and emergency services remains one of the most important steps in preventing harm.

References

1. Welby-Everard, P., Pucci, M., Bradberry, S., Dargan, P., Veiraiah, A., Thanacoody, R., & Elamin, M. E. M. O. (2026). Management of patients with suspected but unidentified poisoning in the emergency department: A joint Royal College of Emergency Medicine and National Poisons Information Service best practice guideline. Emergency Medicine Journal, 43(7), 427–434. https://doi.org/10.1136/emermed-2025-215194

2. Dikme, O., Dikme, O., Kurt, E., Sadillioglu, S., & Erdede, M. O. (2026). Predictors of in-hospital mortality: After a methanol poisoning outbreak in Istanbul. BMC Emergency Medicine, 26(1), 182. https://doi.org/10.1186/s12873-026-01601-z

3. Chowdhury, F. R., Hannan, T. B., Rahman, A. S. M. M., Dewan, G., Hoque, M. M., Kabir, M. J., Ahmed, B. U. M. W., Sayeed, A. A., Tarafder, P., Acherjya, G. K., Sarker, S. K., Marzan, A. A., Mehedi, T., Zaman, N., Chowdhury, S. S. A., Sakib, M. M., Amin, M. A., Abir, A. R., Tanvir, A. M., ... Faiz, M. A. (2026). Clinical and laboratory profile of paraquat poisoning: A toxicological crisis in Bangladesh. The American Journal of Tropical Medicine and Hygiene, 115(1), 176–182. https://doi.org/10.4269/ajtmh.25-0719

4. Huang, C. T., Lai, Y., Xiang, S. Y., Xiao, C. X., Yang, Y. M., Tang, F. K., & Yuan, J. (2026). Treatment of 4 cases of acute organic tin poisoning with blood perfusion combined with continuous veno-venous hemodialysis filtration and sodium dimercaptopropanesulfonate. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, 44(6), 506–509. https://doi.org/10.3760/cma.j.cn121094-20250527-00207

5. Zhu, J., Pan, W., Wang, Y., Yan, K., Fang, Z., & Yang, X. (2026). Quality evaluation of large language model-assisted generation of initial senior physician ward round records for patients with acute poisoning: Cross-sectional study. Journal of Medical Internet Research, 28, e91222. https://doi.org/10.2196/91222

6. Isbister, G. K., Downes, M. A., McArdle, K., Jenkins, S., Lovett, C., & Berling, I. (2026). Poisoning in the elderly is increasing rapidly and is more severe than younger patients. Clinical Toxicology, 64(7), 549–556. https://doi.org/10.1080/15563650.2026.2631131